Paul Wachter, Director at Avalanche Biotechnologies, Inc. ([AAVL]), sold 1,192 shares at $32.80 ($40K) on 2015-05-11, disclosed to the SEC on 2015-05-12.
Scheduled sale ($40k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.80 | 508 | $17K | 41.9% |
| 2 | $33.70 | 552 | $19K | 46.8% |
| 3 | $34.29 | 132 | $5K | 11.4% |
| Total | $33.38 avg | 1,192 | $40K | 100% |
| Filing → |
| [AAVL] | SELL | 2015-06-10 | $46K | — | Filing → |
| [AAVL] | SELL | 2015-06-02 | $43K | — | Filing → |
| [AAVL] | SELL | 2015-05-27 | $44K | — | Filing → |